secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACCENDRA HEALTH INC/VA/ (ACH)
CIK:        0000075252
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001558370-24-001321
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owens & Minor Q4 adjusted EPS $0.69, revenue $2.66B; full year operating cash flow $741M
--------------------------------------------------------------------------------

- Q4 GAAP net income $17.8M vs loss of $58.0M; adjusted net income $53.6M vs $21.7M.
- Full year adjusted EPS $1.36 vs $2.42; GAAP net loss per share $(0.54) vs $0.29.
- Total debt reduced by $403M, net debt reduced by $577M; operating cash flow $741M.
- Full year revenue $10.3B, up 4% from $9.96B; Q4 revenue $2.66B vs $2.55B.
- Patient Direct segment outperformed; Products & Healthcare Services showed sequential improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/0001558370-24-001321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/75252/000155837024001321/tmb-20240220x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-001321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer